The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Share News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sensyne Health Partners With Microsoft To Develop AI Technology

Wed, 28th Oct 2020 15:33

(Alliance News) - Sensyne Health PLC on Wednesday said it has formed a strategic partnership with US-based software giant Microsoft Inc to further develop and refine Sensyne's clinical artificial intelligent and health cloud technologies to improve, augment, and reduce the cost of patient care.

Under the agreement, medical technology company Sensyne will combine its expertise in remote monitoring, clinically led digital technologies and machine learning algorithms with Microsoft's healthcare capabilities such as Health Cloud, Virtual Consult, Healthcare Accelerator, Health Bot, and Azure internet of things for clinical use.

The partnership will increase Sensyne's ability to create scalable and configurable healthcare technologies that are globally deployable and able to meet local, clinical and regulatory needs, the UK-based company explained. Sensyne will have early access to Microsoft tools enabling it to build new products with features to enhance usability and cyber-security.

Shares in Sensyne Health were up 8.5% at 115.0 pence each in London on Wednesday afternoon.

By Tapan Panchal; tapanpanchal@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
7 May 2021 19:23

IN BRIEF: Sensyne Health gets UK heath regulator boost

IN BRIEF: Sensyne Health gets UK heath regulator boost

Read more
7 May 2021 08:55

Sensyne's 'MagnifEye' gets MHRA special use authorisation

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Friday that its 'MagnifEye' software application, which uses AI to automate the accurate reading and analysis of lateral flow diagnostic tests, has been granted special use authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA).

Read more
30 Apr 2021 14:45

Sensyne Health signs research deal with another NHS trust

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed a five-year non-exclusive strategic research agreement (SRA) with the Royal Devon and Exeter NHS Foundation Trust, it announced on Friday.

Read more
30 Apr 2021 14:15

TRADING UPDATES: Henry Boot gets planning boost; Beximco sales jump

TRADING UPDATES: Henry Boot gets planning boost; Beximco sales jump

Read more
12 Mar 2021 13:03

IN BRIEF: Sensyne signs deal with UK government to fund Covid tests

IN BRIEF: Sensyne signs deal with UK government to fund Covid tests

Read more
12 Mar 2021 09:23

Sensyne signs £0.5m Covid-19 test deal with DHSC

(Sharecast News) - Clinical artificial intelligence (AI) technology company Sensyne Health has signed a £0.47m agreement with the Department of Health and Social Care, it announced on Friday, to conduct the second stage of a pilot study of its 'MagnifEye' technology for use with Covid-19 lateral flow diagnostic tests.

Read more
1 Mar 2021 16:41

EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma

EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma

Read more
1 Mar 2021 15:36

Sensyne Health gets UK approval for 'SYNE-COV' algorithm

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Monday that its 'SYNE-COV' machine learning algorithm for Covid-19 risk prediction has achieved regulatory approval for use in the UK.

Read more
1 Mar 2021 15:34

TRADING UPDATES: 1Spatial expects full-year results ahead of forecasts

TRADING UPDATES: 1Spatial expects full-year results ahead of forecasts

Read more
9 Feb 2021 14:43

Sensyne Health signs licence agreement with Excalibur

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed an exclusive licence and development agreement with Excalibur Healthcare Services, it announced on Tuesday, to apply Sensyne's 'MagnifEye' system for use with Excalibur's proprietary lateral flow rapid diagnostic tests across a range of indications, including its Covid-19 antigen test currently being marketed in the UK and Europe.

Read more
9 Feb 2021 11:18

TRADING UPDATES: Northbridge, discoverIE And Tandem Outlook Upbeat

TRADING UPDATES: Northbridge, discoverIE And Tandem Outlook Upbeat

Read more
5 Feb 2021 12:28

EXECUTIVE CHANGES: Iconic Labs CEO; Tiziana Hires Executive Director

EXECUTIVE CHANGES: Iconic Labs CEO; Tiziana Hires Executive Director

Read more
3 Feb 2021 11:07

IN BRIEF: Sensyne Health Launches AI Algorithm For Patient Management

IN BRIEF: Sensyne Health Launches AI Algorithm For Patient Management

Read more
21 Jan 2021 11:32

Sensyne Health Interim Loss Widens But Boasts Of Commercial Progress

Sensyne Health Interim Loss Widens But Boasts Of Commercial Progress

Read more
20 Jan 2021 19:18

IN BRIEF: Sensyne Health Signs Long-Term Deal With NHS Trust

IN BRIEF: Sensyne Health Signs Long-Term Deal With NHS Trust

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.